NAVIVA GROUP:

NAM HUNG VIET Vaccine & biological products joint stock company

TUONG KHUE® Pharmaceutical joint stock company

WINBIO® Joint stock company

SUNMED Investment joint stock company

Total: 59164 Online: 2

Home > News

Gallery & Events

News

Career

10/02/2026

News

LAN TỎA GIÁ TRỊ TỪ BÀI THU HOẠCH TRAINING – “MUỐN XOAY CHUYỂN THỊ TRƯỜNG – PHẢI THAY ĐỔI CHÍNH MÌNH”

21/01/2026

News

NAVIVA Group Welcomes Students from Kelley School of Business, Indiana University (USA)

06/01/2026

News

MAV/06 Varicella Vaccine: Safety and Effectiveness for Global Immunization

24/12/2025

News

Antibiotic-Free Barycela Varicella Vaccine – An Optimal Safety Solution for Children

18/12/2025

News

Important improvements with the Barycela vaccine – The key to WHO-PQ

23/12/2025

News

Building Corporate Culture as a Foundation for Sustainable Development

16/12/2025

News

Barycela chickenpox vaccine – a suitable and reliable choice

29/12/2025

News

Naviva Group Hosts Scientific Conference on Advancements in Varicella Prevention Using the MAV/06 Strain in Ho Chi Minh City

24/09/2025

News

ANNOUNCEMENT ON CHANGE OF COMPANY HEADQUARTERS ADDRESS NAM HUNG VIET VACCINE & BIOLOGICAL PRODUCTS JOINT STOCK COMPANY

29/12/2025

News

Naviva Group Hosts Scientific Conference on Advancements in Varicella Prevention Using the MAV/06 Strain in Da Nang City

26/12/2025

News

Effectiveness of the Barycela Vaccine and the Importance of the Second Dose

05/09/2025

News

The Power of Unity: Naviva Group Thrives at Team Building 2025

13/12/2025

News

WHO Releases New Guidelines on Varicella Vaccination

26/08/2025

News

CONGRATULATIONS ON THE GRAND OPENING CEREMONY OF NAVIVA GROUP’S NEW HEADQUARTERS – 21 Years We Are Together

13/12/2025

News

Early Varicella Vaccination: An Immune Shield for Children’s Health

09/05/2025

News

SUGENTECH – A Comprehensive Solution for Multi-Allergen Testing

13/12/2025

News

Key Updates in the WHO Guidelines for Varicella Vaccines

12/12/2025

News

Korean Second-Generation Varicella Vaccine with Outstanding Advantages Gains Widespread Trust

27/03/2025

News

IVACRIG Rabies Immunoglobulin Scientific Seminar

12/12/2025

News

Key Updates in the WHO Guidelines for Varicella Vaccines

31/03/2025

News

Naviva Tuong Khue – Inspiring Steps at the Danang International Marathon 2025

26/11/2025

News

BARYCELA – A New-Generation Varicella Vaccine from GC Biopharma

14/02/2025

News

Strengthening Influenza Vaccination: The Most Widely Adopted Measure for Public Health Protection

27/12/2024

News

News

LAN TỎA GIÁ TRỊ TỪ BÀI THU HOẠCH TRAINING – “MUỐN XOAY CHUYỂN THỊ TRƯỜNG – PHẢI THAY ĐỔI CHÍNH MÌNH”

NAVIVA Group Welcomes Students from Kelley School of Business, Indiana University (USA)

MAV/06 Varicella Vaccine: Safety and Effectiveness for Global Immunization

Antibiotic-Free Barycela Varicella Vaccine – An Optimal Safety Solution for Children

Important improvements with the Barycela vaccine – The key to WHO-PQ

Building Corporate Culture as a Foundation for Sustainable Development

Barycela chickenpox vaccine – a suitable and reliable choice

Naviva Group Hosts Scientific Conference on Advancements in Varicella Prevention Using the MAV/06 Strain in Ho Chi Minh City

ANNOUNCEMENT ON CHANGE OF COMPANY HEADQUARTERS ADDRESS NAM HUNG VIET VACCINE & BIOLOGICAL PRODUCTS JOINT STOCK COMPANY

Naviva Group Hosts Scientific Conference on Advancements in Varicella Prevention Using the MAV/06 Strain in Da Nang City

Effectiveness of the Barycela Vaccine and the Importance of the Second Dose

The Power of Unity: Naviva Group Thrives at Team Building 2025

WHO Releases New Guidelines on Varicella Vaccination

CONGRATULATIONS ON THE GRAND OPENING CEREMONY OF NAVIVA GROUP’S NEW HEADQUARTERS – 21 Years We Are Together

Early Varicella Vaccination: An Immune Shield for Children’s Health

SUGENTECH – A Comprehensive Solution for Multi-Allergen Testing

Key Updates in the WHO Guidelines for Varicella Vaccines

Korean Second-Generation Varicella Vaccine with Outstanding Advantages Gains Widespread Trust

IVACRIG Rabies Immunoglobulin Scientific Seminar

Key Updates in the WHO Guidelines for Varicella Vaccines

Naviva Tuong Khue – Inspiring Steps at the Danang International Marathon 2025

BARYCELA – A New-Generation Varicella Vaccine from GC Biopharma

Strengthening Influenza Vaccination: The Most Widely Adopted Measure for Public Health Protection

NAVIVA GROUP – Running for the Community!

Community’s Health Is Our Happiness!